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 INTRODUCTION 
Iron oxide-gold nanohybrids (HNPs) are core-shell 
nanoparticles whose properties include inherent magnetism 
from the iron oxide core and surface plasmon resonance 
(SPR) from the gold shell [1,2]. Laser irradiation of these 
HNPs triggers SPR resulting in localised heating to around 
45°C, which can be used for thermal manipulation. 
In order to facilitate the transport of cytotoxic drugs, a 
thermally-labile linker has been developed to attach the 
cytotoxic drugs to the HNP surfaces.  
MATERIALS AND METHODS 
The synthesis of a thiolated cycloadduct with 
gemcitabine was achieved by boc protection of 2-
furanmethane thiol, followed by a Diels Alder reaction with 
4-maleimidobutyric acid n-hydroxysuccinimide ester, 
forming a Diels Alder cycloadduct. This adduct was used to 
perform an amide coupling with previously boc protected 
gemcitabine, before an acid wash deprotection of the boc 
groups, yielded our gemcitabine cycloadduct linker.  
The rate of the retro Diels Alder reaction was monitored 
using 1H NMR spectroscopy. Attachment of the modified 
gemcitabine onto the HNP and release studies at varied 
temperatures was quantified by HPLC. In vitro cytotoxicity 
was determined using MTT assay on BxPC-3 cell lines. 
RESULTS AND DISCUSSION 
The thiolated cycloadduct successfully underwent the 
retro Diels Alder reaction at 37, 45 and 70°C, with 
measurable levels of starting material being detected after 
the first 5 mins. However, no breakdown occurred at room 
temperature. Up to 4 mgmL-1 gemcitabine was capable of 
conjugation onto the HNPs and the release profile was in 
agreement with the NMR data showing temperature and 
time dependant drug release. 
Fig. 1 Retro Diels Alder % conversion of thiolated adduct back into starting 
materials 
In vitro cytotoxicity studies indicated that the 
gemcitabine-HNP formulation was more toxic than the 
unbound drug. Further investigation is required in order to 
determine mechanism of formulation uptake. 
CONCLUSIONS 
These studies highlight the potential of exploitation of 
retro Diels Alder linkers for the reversible binding of drug 
molecules to HNPs in pancreatic cancer therapy. Further in 
vitro and in vivo studies are required in order to elucidate 
the full clinical potential. 
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